PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.32%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.87%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-72.60%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-51.78%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-53.37%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-49.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-49.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.03%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.23%
Slight or no buyback while NXPI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.66%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
329.17%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
25.90%
FCF growth under 50% of NXPI's 94.26%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
53.79%
10Y revenue/share CAGR at 50-75% of NXPI's 79.10%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
17.67%
5Y revenue/share CAGR under 50% of NXPI's 77.31%. Michael Burry would suspect a significant competitive gap or product weakness.
-2.29%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
582.23%
5Y OCF/share CAGR above 1.5x NXPI's 107.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-38.49%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
392.80%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
140.03%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-41.82%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
80.63%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
71.68%
3Y equity/share CAGR above 1.5x NXPI's 42.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
104.00%
Dividend/share CAGR of 104.00% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-78.68%
Negative 5Y dividend/share CAGR while NXPI stands at 169.49%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
15.10%
3Y dividend/share CAGR at 50-75% of NXPI's 20.43%. Martin Whitman might see a weaker short-term approach to distributing cash.
-3.94%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.35%
Inventory growth well above NXPI's 0.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.30%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.11%
Under 50% of NXPI's 3.20%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
14.36%
We have some new debt while NXPI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-3.29%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.26%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.